Key result
Treatment of modifiable risk factors improves rhythm control of atrial fibrillation and demonstrates cost-effectiveness, highlighting the need for comprehensive management.
Why the study?
Does treatment of modifiable risk factors improve rhythm control and outcomes in patients with atrial fibrillation?
Does treatment of modifiable risk factors improve rhythm control and outcomes in patients with atrial fibrillation?
Comprehensive management of modifiable risk factors is essential in atrial fibrillation to improve rhythm control, quality of life, and mortality.
Supports integrating primary prevention into AF care; leaves open need for RCTs to confirm outcomes.
Atrial fibrillation is the most common arrhythmia in the world with continued rising prevalence, significant morbidity and mortality, and a substantial financial burden. It has been associated with numerous modifiable risk factors and chronic medical conditions. Treatment of these modifiable risk factors has improved rhythm control of atrial fibrillation as well as demonstrated cost-effectiveness. Primary prevention of underlying chronic disease should be incorporated into the treatment paradigm for AF. Comprehensive management with integrated care including the patient, allied health professionals, primary care physicians, and specialists will be needed to reverse the epidemiological trends, improve quality of life, and mortality.
No takes yet. Share an insight, caveat, or question.
Frenkel et al. (2020) conducted a review in Atrial fibrillation. Treatment of modifiable risk factors was evaluated. Treatment of modifiable risk factors improves rhythm control of atrial fibrillation and demonstrates cost-effectiveness, highlighting the need for comprehensive management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: